Rapport Therapeutics RAPP
NASDAQ RAPP
$26.20 -3.17 (-10.79%)
As of: Oct 21, 2026 · 11:23 AM EDT

Rapport Therapeutics (RAPP) Tax Provisions (2023)

Updated

Rapport Therapeutics (RAPP) recorded Tax Provisions of $6,000 in Q4 2023, up 500.0% from the prior quarter.

Analysis

Rapport Therapeutics (RAPP) Tax Provisions (2023) Analysis & Trends

For FY2023, Rapport Therapeutics reported Tax Provisions of $10,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,131.24 Bn 1,099.82 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 614.68 Bn 533.21 Bn 17.26 Bn 1.21 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 662.00 Mn
4 Merck 368.01 Bn 322.38 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 298.43 Bn 262.42 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 291.00 Mn
7 Amgen 236.03 Bn 191.43 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 190.92 Bn 165.12 Bn 6.22 Bn 242.00 Mn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn -407.00 Mn
10 Rapport Therapeutics 1.23 Bn 408.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 6,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 2,000.00
API Access

Rapport Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=RAPP&period=max&api_key=YOUR_API_KEY